心脏PET显示变时性功能不全患者β肾上腺素能受体下调
本研究用11C-CGP12177心脏PET比较13例无心力衰竭的变时性功能不全(CTI)患者与6例健康对照的心脏β肾上腺素能受体密度(β-ARD)。CTI患者峰值心率显著低于对照(116.9 ± 11.0 vs. 154.8 ± 14.4 次/分,P < 0.001),总心肌β-ARD亦显著降低(4.3 ± 1.7 vs. 7.0 ± 1.7 pmol/mL,P = 0.005)。结论提示无心力衰竭CTI患者存在β肾上腺素能受体下调。
要点
- 无心力衰竭的CTI患者峰值心率显著低于健康对照。
- CTI患者总心肌β-ARD较对照显著降低。
- β-ARD降低可能是伴或不伴心力衰竭CTI患者的共同特征。
核心结论
- 无心力衰竭的变时性功能不全患者存在心脏β肾上腺素能受体下调。
研究设计与样本
- 用11C-CGP12177心脏PET检测13例无心力衰竭CTI患者与6例健康对照的心脏β-ARD。
主要发现
- CTI患者峰值心率显著低于对照(116.9 ± 11.0 vs. 154.8 ± 14.4 次/分,P < 0.001)。
- CTI患者总心肌β-ARD显著低于对照(4.3 ± 1.7 vs. 7.0 ± 1.7 pmol/mL,P = 0.005)。
关键数值与推荐
- 以每克组织可用的特异性11C-CGP12177最大结合位点数表示β-ARD,采用既定图解法在感兴趣区计算。
临床怎么用
- 心脏11C-CGP12177 PET可用于评估CTI患者心肌β-ARD下调。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The mechanism of chronotropic incompetence (CTI), which has been associated with autonomic dysfunction, has not been elucidated in patients without heart failure (HF). Methods: Cardiac PET using 11C-CGP12177 was performed to investigate the cardiac β-adrenergic receptor density (β-ARD) in 13 patients with CTI without HF and 6 healthy controls. The maximum number of available specific 11C-CGP12177 binding sites per gram of tissue was calculated in regions of interest using an established graphical method. Results: Peak heart rate was significantly lower in CTI patients than in controls (116.9 ± 11.0 vs. 154.8 ± 14.4 beats/min, P < 0.001). β-ARD of the total myocardium was significantly lower in CTI patients than in controls (4.3 ± 1.7 vs. 7.0 ± 1.7 pmol/mL, P = 0.005). Conclusion: β-adrenergic receptor downregulation was demonstrated in patients with CTI without HF. Decreased β-ARD is a common feature in patients with CTI, with or without HF.
引用
- Goto T, Kikuchi S, Mori K, et al. Cardiac β-Adrenergic Receptor Downregulation, Evaluated by Cardiac PET, in Chronotropic Incompetence. J Nucl Med. 2020. PMID: 33443078. doi:10.2967/jnumed.120.253419
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。